Atsena Therapeutics

Atsena Therapeutics is a clinical-stage ocular gene therapy company developing treatments for inherited forms of blindness. It develops an adeno-associated virus technology platform tailored to overcome hurdles presented by inherited retinal disease. Atsena's medical programs include gene therapies for leading forms of Leber congenital amaurosis and Usher syndrome.